Project Details
Description
Company wishes to further understand the mechanism of action of NETs and extracellular Histones in various diseases including autoimmunity and cancers which can be exploited by sulfated poly anions compounds covered in the current Licensed IP or discovery of new compounds in that could be the subject of new IP (i.e. Project IP). Company is looking to collaborate with the ANU with the experience in HIP research in order to assist in achieving the said above goal and agree to fund the research program shown in Part B.
Status | Finished |
---|---|
Effective start/end date | 4/02/21 → 3/02/23 |
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.